Document Classification

Section Type: METHODS

Text: 29 patients with relapsed (n = 17) or refractory (n = 12) AML were treated with the Mito-FLAG protocol consisting of mitoxantrone (7 mg/m (2), days 1/3/5), fludarabine (15mg/m (2), every 12 h, days 1-5), cytarabine (Ara-C) as bolus infusion (1000 mg/m (2) over 1 h, every 12 h, days 1-5) (n = 15) or as continuous infusion (100-150 mg/m (2) over 24 h, days 1-5) (n = 14), and G-CSF (5 mgr ; g / kg/day, day 0 until a neutrophile count of 0. 5 x10 (9) / l).